• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码人α-干扰素受体两种不同可溶性形式的mRNA的鉴定

Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor.

作者信息

Abramovich C, Ratovitski E, Lundgren E, Revel M

机构信息

Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

FEBS Lett. 1994 Feb 7;338(3):295-300. doi: 10.1016/0014-5793(94)80287-4.

DOI:10.1016/0014-5793(94)80287-4
PMID:8307198
Abstract

Transcripts of the human IFN alpha-receptor (IFNAR) gene, lacking the transmembrane (TM) domain were found in human myeloma U266S cells, in addition to the transmembranal IFNAR cDNA. Two different cDNAs encoding such soluble IFNAR forms were identified. Form 1 has a deletion causing a frameshift toward the end of the extracellular (EC) domain predicting a tail of 7 amino acids. Form 2 has two in-frame deletions and conserves most of the intracytoplasmatic domain of IFNAR. The transcripts for the two soluble forms are still found in U266R cells which have lost the transmembranal IFNAR transcript. Human cells seem to have independent mechanisms to synthesize soluble IFN receptors, which may act as competitors outside the cells or carry IFN-mediated functions inside the cell.

摘要

除了跨膜的IFNAR cDNA外,在人骨髓瘤U266S细胞中还发现了缺少跨膜(TM)结构域的人IFNα受体(IFNAR)基因转录本。鉴定出两种编码这种可溶性IFNAR形式的不同cDNA。形式1有一个缺失,导致向细胞外(EC)结构域末端的移码,预测有一个7个氨基酸的尾巴。形式2有两个框内缺失,并保留了IFNAR的大部分胞质内结构域。两种可溶性形式的转录本仍可在已失去跨膜IFNAR转录本的U266R细胞中发现。人类细胞似乎有独立的机制来合成可溶性IFN受体,这些受体可能在细胞外作为竞争者起作用,或者在细胞内发挥IFN介导的功能。

相似文献

1
Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor.编码人α-干扰素受体两种不同可溶性形式的mRNA的鉴定
FEBS Lett. 1994 Feb 7;338(3):295-300. doi: 10.1016/0014-5793(94)80287-4.
2
Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2.小鼠I型干扰素受体新组分IFNAR 2的可溶性和跨膜异构体的克隆与特性分析
J Biol Chem. 1997 Sep 19;272(38):23865-70. doi: 10.1074/jbc.272.38.23865.
3
Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.人I型干扰素受体(IFNAR)-1亚基胞外域的结构-功能研究
J Interferon Cytokine Res. 2000 May;20(5):479-85. doi: 10.1089/10799900050023898.
4
The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.
Blood. 2001 Jan 15;97(2):473-82. doi: 10.1182/blood.v97.2.473.
5
Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression.小鼠Ifnar-2基因启动子内的多个区域赋予基础表达和诱导性表达。
Biochem J. 2002 Jul 15;365(Pt 2):355-67. doi: 10.1042/BJ20020105.
6
Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor.人干扰素α/β受体的可溶性和膜锚定形式。
J Leukoc Biol. 1995 May;57(5):712-8. doi: 10.1002/jlb.57.5.712.
7
Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.突变型U5A细胞可被一种干扰素αβ受体亚基所互补,该亚基由细胞因子受体基因簇一个新成员的可变剪接产生。
EMBO J. 1995 Oct 16;14(20):5100-8. doi: 10.1002/j.1460-2075.1995.tb00192.x.
8
Evidence for glycosphingolipid modification of the type 1 IFN receptor.1型干扰素受体糖鞘脂修饰的证据。
J Immunol. 1994 Oct 15;153(8):3655-63.
9
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.通过可变剪接产生的5-羟色胺2C受体短变体的鉴定、分子克隆及分布
Mol Pharmacol. 1996 Oct;50(4):799-807.
10
Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?RAGE受体及其可溶性形式的组织特异性表达模式——可变剪接受调控的结果?
Biochim Biophys Acta. 2003 Oct 20;1630(1):1-6. doi: 10.1016/j.bbaexp.2003.08.008.

引用本文的文献

1
A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.人肝唾液酸糖蛋白受体主要亚基的一个新剪接变体在肝细胞中编码一种分泌形式。
PLoS One. 2010 Sep 23;5(9):e12934. doi: 10.1371/journal.pone.0012934.
2
Antiviral activities of the soluble extracellular domains of type I interferon receptors.I型干扰素受体可溶性胞外域的抗病毒活性
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6138-43. doi: 10.1073/pnas.111139598. Epub 2001 May 8.
3
LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein.
LIM蛋白KyoT2通过与RBP-J DNA结合蛋白结合来负向调节转录。
Mol Cell Biol. 1998 Jan;18(1):644-54. doi: 10.1128/MCB.18.1.644.
4
A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor.一种蛋白质精氨酸甲基转移酶与I型干扰素受体中IFNAR1链的胞质内结构域结合。
EMBO J. 1997 Jan 15;16(2):260-6. doi: 10.1093/emboj/16.2.260.
5
Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.I型干扰素受体的IFNAR链及相关表面蛋白在响应IFN-α和IFN-β时的差异性酪氨酸磷酸化
EMBO J. 1994 Dec 15;13(24):5871-7. doi: 10.1002/j.1460-2075.1994.tb06932.x.